View More Recent Stories
-
Citi Reiterates Sell Rating on PTC Therapeutics (PTCT), 'PIVOT-HD Data Update Supportive, But Expectations Measured to this Point'
-
PTC Therapeutics (PTCT) Reports Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects
